ezetimibe has been researched along with bafilomycin a1 in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (bafilomycin a1) | Trials (bafilomycin a1) | Recent Studies (post-2010) (bafilomycin a1) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 1,120 | 1 | 484 |
| Protein | Taxonomy | ezetimibe (IC50) | bafilomycin a1 (IC50) |
|---|---|---|---|
| P2X purinoceptor 3 | Homo sapiens (human) | 0.755 | |
| V-type proton ATPase subunit S1 | Homo sapiens (human) | 0.1 | |
| Vacuolar proton pump subunit B | Gallus gallus (chicken) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, E; Kim, L; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ | 1 |
1 other study(ies) available for ezetimibe and bafilomycin a1
| Article | Year |
|---|---|
Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats.
Topics: Animals; Anticholesteremic Agents; Autophagy; Biomarkers; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Ezetimibe; Fatty Liver; Gene Expression Regulation; Hepatocytes; Lipids; Liver; Macrolides; Male; Obesity; Palmitic Acid; Rats, Inbred OLETF; RNA, Messenger | 2015 |